• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?

作者信息

Locatelli Francesco, Aljama Pedro, Barany Peter, Canaud Bernard, Carrera Fernando, Eckardt Kai-Uwe, Macdougall Iain C, Macleod Alison, Hörl Walter H, Wiecek Andrzej, Cameron Stewart

出版信息

Nephrol Dial Transplant. 2004 Feb;19(2):288-93. doi: 10.1093/ndt/gfg489.

DOI:10.1093/ndt/gfg489
PMID:14736947
Abstract
摘要

相似文献

1
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?促红细胞生成素和抗体介导的纯红细胞再生障碍性贫血：我们现在的情况如何，未来又将何去何从？
Nephrol Dial Transplant. 2004 Feb;19(2):288-93. doi: 10.1093/ndt/gfg489.
2
Pure red-cell aplasia and recombinant erythropoietin.
N Engl J Med. 2002 May 16;346(20):1584-6; author reply 1584-6.
3
Low-dose cyclosporin therapy for recombinant erythropoietin-induced pure red-cell aplasia.
Nephrol Dial Transplant. 2004 Feb;19(2):479-81. doi: 10.1093/ndt/gfg535.
4
Pure red cell aplasia induced by erythropoiesis-stimulating agents.促红细胞生成素诱导的纯红细胞再生障碍性贫血。
Clin J Am Soc Nephrol. 2008 Jan;3(1):193-9. doi: 10.2215/CJN.02440607.
5
Pure red cell aplasia secondary to treatment with erythropoietin.促红细胞生成素治疗继发的纯红细胞再生障碍。
J Nephrol. 2003 Jul-Aug;16(4):461-6.
6
Pure red cell aplasia due to follow-on epoetin.因后续促红细胞生成素导致的纯红细胞再生障碍。
Kidney Int. 2008 Dec;74(12):1617-22. doi: 10.1038/ki.2008.230. Epub 2008 Jun 11.
7
Pure red-cell aplasia: an emerging epidemic in dialysis patients?纯红细胞再生障碍性贫血：透析患者中一种新出现的流行病？
Perit Dial Int. 2003 Jul-Aug;23(4):317-9.
8
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.重组促红细胞生成素产品治疗后抗促红细胞生成素抗体介导的纯红细胞再生障碍性贫血：风险最小化建议
J Am Soc Nephrol. 2004 Oct;15(10):2728-34. doi: 10.1097/01.ASN.0000140219.28618.9F.
9
Drug-induced autoimmune red-cell aplasia.药物性自身免疫性红细胞再生障碍
N Engl J Med. 2002 Feb 14;346(7):522-3. doi: 10.1056/NEJM200202143460711.
10
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.接受重组促红细胞生成素治疗的患者中的纯红细胞再生障碍和抗促红细胞生成素抗体
N Engl J Med. 2002 Feb 14;346(7):469-75. doi: 10.1056/NEJMoa011931.

引用本文的文献

1
Design and Evaluation of a Multiplexed Assay to Assess Human Immunogenicity Against Humira®.评估针对修美乐®的人免疫原性的多重检测方法的设计与评价
AAPS J. 2020 Aug 3;22(5):104. doi: 10.1208/s12248-020-00487-4.
2
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.慢性肾脏病相关性贫血大鼠模型中对重组人促红细胞生成素治疗的抵抗性
Int J Mol Sci. 2015 Dec 25;17(1):28. doi: 10.3390/ijms17010028.
3
Pure red cell aplasia after treatment of renal anaemia with epoetin theta.使用促红细胞生成素θ治疗肾性贫血后出现的纯红细胞再生障碍。
Clin Kidney J. 2013 Oct;6(5):539-42. doi: 10.1093/ckj/sft085. Epub 2013 Aug 13.
4
Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.残肾大鼠模型中铁调素代谢紊乱、贫血以及肾脏缺氧、炎症和纤维化。
PLoS One. 2015 Apr 13;10(4):e0124048. doi: 10.1371/journal.pone.0124048. eCollection 2015.
5
Use of agents stimulating erythropoiesis in digestive diseases.促红细胞生成剂在消化系统疾病中的应用。
World J Gastroenterol. 2009 Oct 7;15(37):4675-85. doi: 10.3748/wjg.15.4675.
6
Recombinant human epoetin beta in the treatment of renal anemia.重组人促红素β在肾性贫血治疗中的应用。
Ther Clin Risk Manag. 2007 Jun;3(3):433-9.
7
Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.用于检测抗促红细胞生成素α抗体的多重流式细胞术磁珠免疫测定法的可行性
Clin Vaccine Immunol. 2007 Sep;14(9):1165-72. doi: 10.1128/CVI.00157-07. Epub 2007 Jul 18.
8
Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.促红细胞生成素类药物的鉴别因素：慢性肾脏病贫血治疗的选择指南
Drugs. 2004;64(5):499-509. doi: 10.2165/00003495-200464050-00004.